Home Page > Hearing - 110th Congress

HEARING

Reauthorization of the Prescription Drug User Fee Act

Subcommittee on Health
Tuesday, April 17, 2007
10:00 a.m. 2123 Rayburn House Office Building

Hearing Webcast

(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)

Connect to the Video Webcast of this Hearing (100 kbps) or Download

Windows Media Player is required for Committee Webcasts.

Witness List & Prepared Testimony (pdf files)

Panel I
Dr. Theresa M. Mullin Assistant Commissioner for Planning Food and Drug Administration 5600 Fishers Lane Rockville, MD 20857
Panel II
Dr. Alan Goldhammer Deputy Vice President for Regulatory Affairs Pharmaceutical Research and Manufacturers of America (PhRMA) 950 F Street, N.W. Washington, D.C. 20004	Mr. James Thew Patient Advocate Amyotrophic Lateral Sclerosis (ALS) Association 1034 Minns Drive, Unit B Machesney Park, IL 61115
Ms. Kay Holcombe Senior Policy Advisor Genzyme Corporation 1850 K Street, N.W. Suite 650 Washington, D.C. 20006	Mr. William K. Vaughan Senior Policy Advocate Consumers Union 1101 17th Street, N.W., Suite 500 Washington, D.C. 20036
Mr. William Hubbard Senior Advisor Coalition for a Stronger FDA 202 Weaver Mine Trail Chapel Hill, NC 27517

Hearing Transcript

Not available at this time. The printed hearing should be available within 90-120 days of the conclusion of the hearing. When available, the text of the printed hearing may be viewed at the U.S. Government Printing Office Web site.